Brightly coloured pharmaceutical medication, including antibiotics, paracetamol, Ibuprofen and cold relief tablets. Currently, the FDA mostly relies on the drug manufacturing industry to police itself, only sporadically inspecting manufacturing sites. That approach has been strained by the increasing proportion of generic drugs and drug ingredients made for the U.S. market in countries like China and India. (Photo: Chris Ratcliffe/Bloomberg)
U.S. regulators plan to revamp rules governing how medicines are manufactured, in an effort to ensure the safety of the nation's drug supply as recalls of contaminated imports from developing countries widen.
Contamination, impurities
"We've seen a lot of instances of adulterated products — contamination, impurities — recently," said Food and Drug Administration (FDA) Commissioner Scott Gottlieb, who plans to leave his post next month, in an interview. "The underlying causes have been traced back to manufacturing, inadequate quality controls and generally poor management oversight."
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
